Safety and utility of flecainide acetate in the routine care of patients with supraventricular tachyarrhythmias: Results of a multicenter trial

American Journal of Cardiology

Volumn 77, Issue 3, 1996, Pages 72A-82A

  Hopson, James R ^a   Buxton, Alfred E ^a   Rinkenberger, Robert L ^a   Nademanee, Koonlawee ^a   Heilman, James M ^a   Kienzle, Michael G ^a  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIGOXIN; FLECAINIDE ACETATE;

ADOLESCENT; ADULT; AGED; CLINICAL PROTOCOL; CLINICAL TRIAL; CONFERENCE PAPER; CONGESTIVE HEART FAILURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEADACHE; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART SUPRAVENTRICULAR ARRHYTHMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SUPRAVENTRICULAR TACHYCARDIA; VERTIGO; VISUAL IMPAIRMENT;

EID: 0030046637     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(97)89121-7     Document Type: Conference Paper

References (48)

1. Anderson JL, Gilbert EM, Alpert BL, Henthorn RW, Waldo AL, Bhandari AK, Hawkinson RW, Pritchett ELC, and the Flecainide Supraventricular Tachycardia Study Group. Prevention of symptomatic recurrences of paroxysmal atrial fibrillation in patients initially tolerating antiarrhythmic therapy. Circulation 1989:80;1557-1570.
2. Pritchett ELC, DaTorre SD, Platt ML, McCarville SE, Hougham AJ, for the Flecainide Supraventricular Tachycardia Study Group. Flecainide acetate for treatment of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation: dose-response studies. J Am Coll Cardiol 1991;17:297-303.
3. Henthorn RW, Waldo AL, Anderson JL, Gilbert EM, Alpert BL, Bhandari AK, Hawkinson RW, Pritchett ELC, and the Flecainide Supraventricular Tachycardia Study Group. Flecainide acetate prevents recurrence of symptomatic paroxysmal supraventricular tachycardia. Circulation 1991;1:119-125.
4. Anderson JL, for the Flecainide Supraventricular Tachyarrhythmia Investigators. Long-term safety and efficacy of flecainide in the treatment of supraventricular tachyarrhythmias: the United States experience. Am J Cardiol 1992; 5(suppl):11A-17A.
5. Cockrell JL, Scheinman MM, Titus C, Helmy I, Langberg JJ, Lee MA, Griffin JC. Safety and efficacy of oral flecainide therapy in patients with atrioventricular re-entrant tachycardia. Ann Intern Med 1991;114:189-194.
6. Pritchett ELC, Wilkinson WE. Mortality in patients treated with flecainide and supraventricular arrhythmias. Am J Cardiol 1991;67:976-980.
7. SAS Institute, Inc. SAS User's Guide: Statistics, Version 5 Edition. Cary, NC: SAS Institute, 1985:956.
8. Hollander M, Wolfe DA. Nonparametric Statistical Methods. New York: John Wiley & Sons, 1973.
9. Winer BJ. Statistical Principles in Experimental Design, 2nd ed. New York: McGraw-Hill, 1971.
10. Cardiac Arrhythmia Suppression Trial Investigators. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. New Engl J Med 1989;321:406-411.
11. Morganroth J, Horowitz LN. Flecainide: its proarrhythmic effect and expected changes on the surface electrocardiogram. Am J Cardiol 1984;:53(suppl): 89B-94B.
12. Goy JJ, Kaufmann U, Sigwart U. Restoration of sinus rhythm with flecainide in patients with atrial fibrillation. Am J Cardiol 1988;62(suppl):38D-40D.
13. Crijns HJ, Van Wijk LM, Van Gilst WH, Kingma JH, Van Gelder IC, Lie KI. Acute conversion of atrial fibrillation to sinus rhythm: clinical efficacy of flecainide acetate. Comparison of two regimens. Eur Heart J 1988;9:634-638.
14. Suttorp MJ, Kingma JH, Jessurun ER, Lie-A-Huen L, Van Hemel NM, Lie KI. The value of class IC antiarrhythmic drugs for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm. J Am Coll Cardiol 1990;16:1722-1727.
15. Crijns HJ, Van Gelder IC, Van Gilst WH, Hillege H, Goselink AM, Lie KI. Serial antiarrhythmic drug treatment to maintain sinus rhythm after electrical cardioversion for chronic atrial fibrillation and atrial flutter. Am J Cardiol 1991;68:335-341.
16. Kingma JH, Suttorp MJ. Acute pharmacologic conversion of atrial fibrillation and flutter: the role of flecainide, propafenone, and verapamil. Am J Cardiol 1992;70(suppl):56A-60A.
17. Kannel WB, Abbott RD, Savage DD, McNamara PM. Epidemiologic features of atrial fibrillation. The Framingham study. N Engl J Med 1982;306: 1018-1022.
18. Coplen SE, Antman EM, Berlin JA, Hewitt P, Chalmers TC. Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials. Circulation 1990;82:1106-1116.
19. Berns E, Rinkenberger RL, Jeang MK, Dougherty AH, Jenkins M, Naccarelli GV. Efficacy and safety of flecainide acetate for atrial tachycardia or fibrillation. Am J Cardiol 1987;59:1337-1341.
20. Van Gelder IC, Crijns HJ, Van Gilst WH, Van Wijk LM, Hamer HP, Lie KI. Efficacy and safety of flecainide acetate in the maintenance of sinus rhythm after electrical cardioversion of chronic atrial fibrillation or atrial flutter. Am J Cardiol 1989;64:1317-1321.
21. Sonnhag C, Kallryd A, Nylander E, Ryden L. Long-term efficacy of flecainide in paroxysmal atrial fibrillation. Acta Med Scand 1988;224:563-569.
22. Mary-Rabin L, Kulbertus HE. Clinical efficacy of flecainide acetate in atrial fibrillation. Cardiology 1990;77:443-449.
23. Rinkenberger RL, Naccarelli GV, Berns E, Dougherty AH. Efficacy and safety of class IC antiarrhythmic agents for the treatment of coexisting supraventricular and ventricular tachycardia. Am J Cardiol 1988;62(suppl):44D-55D.
24. Chouty F, Coumel P. Oral flecainide for prophylaxis of paroxysmal atrial fibrillation. Am J Cardiol 1988;62(suppl):35D-37D.
25. Van Wijk LM, den Heijer P, Crijns HJ, van Gilst WH, Lie KI. Flecainide versus quinidine in the prevention of paroxysms of atrial fibrillation. J Cardiovasc Pharmacol 1989;13:32-36.
26. Sihm I, Hansen FA, Rasmussen J, Pedersen AK. Thygesen K. Flecainide acetate in atrial flutter and fibrillation. The arrhythmogenic effects. Eur Heart J 1990;11:145-148.
27. Pietersen AH, Hellemann H. Usefulness of flecainide for prevention of paroxysmal atrial fibrillation and flutter. Danish-Norwegian Flecainide Multicenter Study Group. Am J Cardiol 1991:67:713-717.
28. Leclercq JF, Couty F, Denjoy I, Coumel P, Slama R. Flecainide in quinidine-resistant atrial fibrillation. Am J Cardiol 1992;70(suppl):62A-65A.
29. Hohnloser SH, Zabel M. Short- and long-term efficacy and safety of flecainide acetate for supraventricular arrhythmias. Am J Cardiol 1992;70(suppl): 3A-9A
30. Clementy J, Dulhoste MN, Laiter C, Denjoy I, Dos Santos P. Flecainide acetate in the prevention of paroxysmal atrial fibrillation: a nine-month follow-up of more than 500 patients. Am J Cardiol 1992;70(suppl):44A-49A.
31. Grey E, Silverman DI. Efficacy of type 1C antiarrhythmic agents for treatment of drug resistant atrial fibrillation. Pacing and Clin Electrophys 1993;16: 2235-2240.
32. Lau CP, Leung WH, Wong CK. A randomized double-blind crossover study comparing the efficacy and tolerability of flecainide and quinidine in the control of patients with symptomatic paroxysmal atrial fibrillation. Am Heart J 1992;124:645-650.
33. Hughes MM, Trohman RG, Simmons TW, Castle LW, Wilkoff BL, Morant VA, Maloney JD. Flecainide therapy in patients treated for supraventricular tachycardia with near normal left ventricular function. Am Heart J 1992;123:408-412.
34. Hamer AW, Strathmore N, Vohra JK, Hunt VD. Oral flecainide, sotalol, and verapamil for the termination of paroxysmal supraventricular tachycardia. Pace Clin Electrophysiol 1993;16:1394-1400.
35. Anderson JL, Platt ML, Guarnieri T, Fox TL, Maser MJ, Pritchett EL. Flecainide acetate for paroxysmal supraventricular tachyarrhythmias. The flecainide supraventricular tachycardia study group. Am J Cardiol 1994;74:578-584.
36. Furlanello F, Guamerio M, Inama G, Vergara G, Del Greco M, Bertoldi A, Dallago M. Long-term follow-up of patients with inducible supraventricular tachycardia treated with flecainide or propafenone: therapy guided by transesophageal electropharmacologic testing. Am J Cardiol 1992;70(suppl):19A-25A.
37. Van Wijk LM, Crijns HJ, Van Gilst WH, Wesseling H, Lie KI. Flecainide acetate in the treatment of supraventricular tachycardias: value of programmed electrical stimulation for long-term prognosis. Am Heart J 1989;117:365-369.
38. Zeigler V, Gillette PC, Ross BA, Ewing L. Flecainide for supraventricular arrhythmias in children and young adults. Am J Cardiol 1988;62:818-820.
39. Hoff PI, Tronstad A, Oie B, Ohm OJ. Electrophysiologic and clinical effects of flecainide for recurrent paroxysmal supraventricular tachycardia. Am J Cardiol 1988;62:585-589.
40. Kuck KH, Kunze KP, Schluter M, Duckeck W. Encainide versus flecainide for chronic atrial and junctional ectopic tachycardia. Am J Cardiol 1988;62(suppl): 37L-44L.
41. Zee-Cheng CS, Kim SS, Ruffy R. Flecainide acetate for treatment of bypass tract mediated reentrant tachycardia. Am J Cardiol 1988;62(suppl):23D-28D.
42. Kim SS, Smith P, Ruffy R. Treatment of atrial tachyarrhythmias and preexcitation syndrome with flecainide acetate. Am J Cardiol 1988;62(suppl):29D-34D.
43. Neuss H, Schlepper M. Long-term efficacy and safety of flecainide for supraventricular tachycardia. Am J Cardiol 1988;62(suppl):56D-61D.
44. Lau CP, Davies DW, Mehta D, Ward DW, Camm AJ. Flecainide acetate in the treatment of tachycardias associated with Mahaim fibers. Eur Heart J 1987;8:832-839.
45. Wiseman MN, Elstob JE, Camm AJ, Nathan AW. A study of the use of flecainide acetate in the long-term management of cardiac arrhythmias. Pacing Clin Electrophysiol 1990;13:767-775.
46. Capucci A, Lenzi T, Boriani G, Trisolino G, Binetti N, Cavazza M, Fontana G, Magnani B. Effectiveness of loading oral flucainide for converting recent-onset atrial fibrillation to sinus rhythm in patients without organic heart disease or with only systemic hypertension. Am J Cardiol 1992;70:69-72.
47. Kuhlkamp V, Schmid F, Risler T, Seipel L. Randomized comparison of flecainide and cibenzoline in the conversion of atrial fibrillation. Int J Cardiol 1991;31:65-69.
48. Falk RH. Flecainide-induced ventricular tachycardia and fibrillation in patients treated for atrial fibrillation. Ann Intern Med 1989;111:107-111.